SkinHealth Systems Launched New Cosmetic Device in Europe
The company has introduced its SkinStylus SteriLock MicroSystem across six European markets to expand its aesthetic offerings.
Updated on Oct. 1, 2026 in Beauty
Live Poll
Do you believe professional cosmetic skin treatments are becoming more accessible in your area?
SkinHealth Systems has officially released the SkinStylus SteriLock MicroSystem for cosmetic use across the UK, Ireland, Germany, France, Spain, and Portugal. This launch leverages the company's existing commercial infrastructure and provider network in the region.
Why it matters
The introduction of this device is part of a broader corporate effort to establish an integrated medical aesthetics ecosystem. The move marks a significant step in scaling the company's treatment capabilities for international providers.
The rollout follows the company's 2023 acquisition of the SkinStylus platform. The launch is currently limited to these six countries, with future expansion into broader distributor markets pending for 2027.
The players
SkinHealth Systems
A developer of medical aesthetic technologies that acquired the SkinStylus brand to build a broader aesthetic ecosystem.
Hydrafacial
A skin health company whose European commercial organization and existing provider relationships are facilitating the distribution of the new device.
The details
The SkinStylus SteriLock MicroSystem utilizes adjustable settings to provide customizable treatment delivery. It functions through dedicated SteriLock cartridge options designed for aesthetic applications. Distribution is handled via the existing Hydrafacial European commercial organization, which integrates the new device into an established framework of provider relationships.
Timeline
2023: SkinHealth Systems acquired the SkinStylus platform.
October 01, 2026: The device launched across the UK, Ireland, Germany, France, Spain, and Portugal.
2027: Product availability is scheduled to expand into select distributor markets.
Health Landscape
The release sits within an ongoing industry trend of consolidating aesthetic technologies into unified, provider-focused ecosystems. This model follows the historical arc of leveraging established medical sales networks to scale new cosmetic dermatology platforms internationally.
Patients interested in the SkinStylus system should consult with their local aesthetic provider to determine if the new device is available at their clinic. As this is a cosmetic system, any clinical questions regarding suitability for your skin type should be discussed with a dermatologist.
The takeaway
The arrival of this new micro-system reflects a broader trend of integrating cosmetic devices into existing professional aesthetics networks. If you are considering micro-treatments, always verify that your provider is properly trained and authorized to use the specific equipment in your region.
What happens next
Product availability is scheduled to expand into select additional distributor markets beginning in 2027.
Further reading
For more information on the latest innovations in cosmetic dermatological treatments, visit our Beauty section.
Live Poll
Do you believe professional cosmetic skin treatments are becoming more accessible in your area?
